News
6/27/11
New Wool.labs report shows patients with diabetes troubled by emergency room care. See the preview of “Diabetes Patients and the Emergency Room.”
This reports looks at the Emergency Room through the eyes of the diabetes patient from 2004 until today. Wool.labs provides quantitative and qualitative analyses as well as insights into current patients and ER staff behavior and the implications for the future.
3/22/2011
The wool.labs Social State of diabetes report series continues with “Actos, the impact of social media on the brand.”
The purpose of this study was to understand how patients speak about Actos in candid conversations, publically available on the internet. This will give pharmaceutical brands and the FDA an opportunity to listen and learn from patients and healthcare providers in order to track changing patient sentiment, identify emerging trends as well as gauge the strength of those trends.
11/10/2010
Wool.labs publishes second Patient Social Intelligence Report, A study of patient understanding of anti-coagulation in social media distributed by SmartBrief, showing widely varying attitudes regarding the appropriate use of anticoagulants like Coumadin and other blood thinners
Medical Marketing and Media publishes exclusive story on Wool.labs’ A study of patient understanding of anti-coagulation in social media http://www.mmm-online.com/in-coumadin-banter-lessons-for-marketers-of-new-blood-thinners/article/181809/
10/28/2010
Wool.labs kicked of its “Cocktail Convention” series with a discussion about patients’ perspectives on managing their health as seen through dialogue in social media. Hosted at the National Constitution Center in Philadelphia, health care marketing professionals gathered to connect and discuss these trends and the implications for their businesses.
A panel discussion followed a cocktail reception and dinner. Panelists represented patient advocacy, healthcare marketing and patients themselves – all bringing their unique points of view to the discussion.
Click here to see panelist bios
Following the panel discussion, panelists and attendees broke into smaller groups to discuss how these trends and insights about patient sentiment could have an impact on how they communicate with patients.
The series will continue quarterly with new industries and new topics each session. Updates will be posted here when the new date and topic is announced.
For those of you that attended, we would like to hear your feedback to make the next event even better. We'd appreciate it.
8/31/2010
Wool.labs publishes first Patient Social Intelligence Report, distributed by SmartBrief, demonstrating significant patient sentiment change regarding Avandia over a 5-year period. http://smartblogs.com/socialmedia/2010/08/26/drug-companies-marketers-need-to-monitor-their-brands-on-social-media/
Press Release here:
http://news.yahoo.com/s/prweb/20100901/bs_prweb/prweb4450224
Medical Marketing and Media publishes exclusive story on Wool.labs’ Avandia patient sentiment study and how pharma companies can use that information effectively. http://www.mmm-online.com/avandia-warning-signs-seen-online-as-early-as-04/article/177982/
5/25/2010
Scott Reese, Wool.labs CEO, Presents “Social Graces: Stories from the front line of adapting enterprise policies and guidelines” at Social Media Plus Summit, Philadelphia PA
http://socialmediaplus.com/speakers/
3/26/2010
Steve Chiles, Wool.labs Chief Marketing Officer, delivers the keynote address to the Society of Consumer Affairs Professionals in Detroit to over 75 automotive industry executives
2/11/2010
Scott Reese, Wool.labs CEO, panelist on customer engagement to the RE/MAX International Realtors Convention in Orlando FL. Simulcast to 70 counties.
2/18/2010
Scott Reese Wool.labs CEO, MM&M Webinar “A brand new way to capture behavior metrics and unlock ROI across integrated channels“http://www.mmm-online.com/a-brand-new-way-to-capture-behavior-metrics-and-unlock-roi-across-integrated-channels/article/162245/
12/16.09
Michele Bennett, Wool.labs COO presents social analytics case studies at Web Analytics Wednesday with Razorfish
http://www.webanalyticsdemystified.com/wednesday/
11/1/09
Wool Labs has been accepted into the Microsoft® BizSpark™ program. Microsoft® BizSpark™ is a global program designed to help accelerate the success of early stage startups by providing key resources and helping them tap into a rich, vibrant ecosystem of peers, partners and support resources around the globe.
10/6/09
Scott Reese, CEO speaks at Health 2.0 in San Francisco.
Scott presents WebDig and speaks about Active Intelligence to the preeminent body of health innovators.
From Health 2.0: “We first met Scott when he was at the agency Digitas, and we struggled then to keep up with his understanding of cutting edge technology. Now he’s putting that to work at Wool Labs where WebDig is one of the most interesting examples we’ve seen of real time search. It’s currently helping pharma firms understand what’s being said about their products right now online in social networks, tweets and blogs.”
9/15/09
Wool Labs announces it’s latest new hire of Steven Chiles as Chief Marketing Officer. Steve Chiles is a 15-year digital marketing professional who has worked across multiple industries to develop business-driving strategies. Partnering with top brands and executive teams - as Vice President, Marketing at DIGITAS Health he has led agency of record relationships and strategic initiatives for clients such as Johnson and Johnson, Astra Zeneca, Pharmacia, Pfizer, Galderma, Schering-Plough and Merck. With Refinery (now G2 Interactive) he led the Campbell’s Soup Company digital agency of record business and has also worked with Miller Brewing Company, ARAMARK, United Technologies and Southern New England Telephone, among others. Steve has developed accounts and relationships consistently through client partnership, channel innovation and business insight. His breadth of domestic and global experience gives him deep knowledge of brands and brand strategy development as well as the ability to consult with clients of all types to solve problems and bring new ideas to the table.
8/14/09
WebDig receives comprehensive third party evaluation comparing Web Dig to eight other listening platforms and receives their highest rating. The report highlight are:
- WebDig does not use a white list of sites that is provided by the client. WebDig searches the entire internet for all possible sites that contain conversations around the topic and brand we are searching for
- WebDig does not limit the number of conversations that is collected or made searchable.
- WebDig has a rigorous and constantly improving approach to QA methodology that is second to none. In some cases, QA simply does not exist.
Radian 6 in particular, and others, are unable to gather publicly available information from WebMD because WebMD does not provide RSS feeds for conversations or an open API. They will never be able to provide the breadth and accuracy of conversation metrics that WebDig provides based on their current platform.
There are also major disadvantages to the fields data collection methodology:
- They will only ever be able to capture a small percentage of conversations.
- They will not be able to get data from some highly influential and popular sites ie. WebMD
- They can not offer comprehensive metrics on conversations
- They will never discover new or obscure sites that may be extremely influential
WebDig does not share these disadvantages. WebDig is a year, maybe two, ahead of the field in terms of quality and quantity of the data. “
7/23/2009
wool.labs is participating in round table discussions at the Social Communications & Healthcare conference
Follow our coverage on Twitter @webdig